High rates of recurrence in HIV-Infected and HIV-Uninfected patients with Tuberculosis

Journal of Infectious Diseases

Volumn 201, Issue 5, 2010, Pages 704-711

  Glynn, Judith R ^a   Murray, Jill ^c,d   Bester, Andre ^f   Nelson, Gill ^c,d   Shearer, Stuart ^e   Sonnenberg, Pam ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c National Institute for Occupational Health Johannesburg   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e GOLD FIELDS LIMITED   (South Africa)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; REINFECTION; SEROCONVERSION; SOUTH AFRICA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; COHORT STUDIES; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MALE; RECURRENCE; RETROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS;

EID: 76449113203     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/650529     Document Type: Article

References (16)

1. Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 2003; 3:282-287.
2. Verver S, Warren RM, Beyers N, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171:1430-1435.
3. Korenromp EL, Scano F,Williams BG, Dye C, Nunn P. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis 2003; 37:101-112.
4. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. How soon after infection with HIV does the risk of tuberculosis start to increase? a retrospective cohort study in South African gold miners. J Infect Dis 2005; 191:150-158.
5. van der Sande MA, Schim van der Loeff MF, Bennett RC, et al. Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS 2004; 18:1933-1941.
6. Churchyard GJ, Fielding K, Charalambous S, et al. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? AIDS 2003; 17:2063-2070.
7. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet 1999; 353:1843-1847.
8. Charalambous S, Grant AD, Moloi V, et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis 2008; 12:942-948.
9. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 2000; 356:1470-1474.
10. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey- Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358:1687-1693.
11. Crampin AC, Mwaungulu JN, Mwaungulu FD, et al. Recurrent tuberculosis: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS 2010; 24:417-426.
12. Lambert ML, Hasker E, van Deun A, Roberfroid D, van der Stuyft P. Rifampicin and recurrence of tuberculosis among patients infected with HIV. Clin Infect Dis 2003; 37:1719-1720.
13. Glynn JR, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P. Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines. AIDS 2008; 22:1859-1867.
14. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey Fausett P, Shearer S. HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. AIDS 2004; 18:657-662.
15. Sonnenberg P, Murray J, Shearer S, Glynn JR, Kambashi B, Godfrey-Faussett P. Tuberculosis treatment failure and drug resistance-same strain or reinfection? Trans R Soc Trop Med Hyg 2000; 94:603-607.
16. Cowie RL. Silicotuberculosis: long-term outcome after short-course chemotherapy. Tuber Lung Dis 1995; 76:39-42